PAPER Didcote L, Vitoratou S, Al-Chalabi A, Goldstein LH
SEARCH RESULTS
330029 RESULTS
PAPER Zakaria N, Wan Harun WM, Mohammad Latif MA, Azaman SN, Abdul Rahman MB, Faujan NH
Effects of anthocyanidins on the conformational transition of Aβ(1-42) peptide: Insights from molecular docking and molecular dynamics simulations.
J Mol Graph Model. 2024 Feb 15;129:108732. PubMed: 38412813PAPER Qasrawi DO, Al-Ghabkari A, Khan RM, Petrotchenko EV, Montero-Odasso M, Borchers CH
A Simplified Proteomics LC-MRM-MS Assay for Determination of apoE Genotypes in Plasma Samples.
J Proteome Res. 2024 Feb 27; PubMed: 38412507PAPER Scott IA
Monoclonal antibodies for treating early Alzheimer disease-a commentary on recent 'positive' trials.
Age Ageing. 2024 Feb 1;53(2) PubMed: 38411409PAPER Rodrigues JF, Rodrigues LP, Filho GG
Alzheimer's Disease and Suicide: An Integrative Literature Review.
Curr Alzheimer Res. 2024 Feb 22; PubMed: 38409712PAPER Stojakovic A, Trushin S, Sheu A, Khalili L, Chang SY, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B, Flannery PJ, Dehankar M, Funk CC, Wilkins J, Stepanova A, O'Hagan T, Galkin A, Nesbitt J, Zhu X, Tripathi U, Macura S, Tchkonia T, Pirtskhalava T, Kirkland JL, Kudgus RA, Schoon RA, Reid JM, Yamazaki Y, Kanekiyo T, Zhang S, Nemutlu E, Dzeja P, Jaspersen A, Kwon YI, Lee MK, Trushina E
Author Correction: Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice.
Commun Biol. 2024 Feb 26;7(1):234. PubMed: 38409374PAPER
Sclerostin secreted from bone mediates cognitive decline in the brains of aged and Alzheimer's disease mice.
Nat Metab. 2024 Mar;6(3):394-395. PubMed: 38409605PAPER He W, Shi X, Dong Z
The roles of RACK1 in the pathogenesis of Alzheimer's disease.
J Biomed Res. 2024 Feb 27;:1-12. PubMed: 38410996PAPER Balana AT, Mahul-Mellier AL, Nguyen BA, Horvath M, Javed A, Hard ER, Jasiqi Y, Singh P, Afrin S, Pedretti R, Singh V, Lee VM, Luk KC, Saelices L, Lashuel HA, Pratt MR
Author Correction: O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology.
Nat Chem Biol. 2024 Feb 27; PubMed: 38413747PAPER Wang C, Yang M, Liu D, Zheng C
Metabolic rescue of α-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans.
Cell Rep. 2024 Feb 26;43(3):113865. PubMed: 38412096PAPER Urmila A, Kundlik R, Mathure D
Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer's Disease.
Cent Nerv Syst Agents Med Chem. 2024 Feb 23; PubMed: 38409724PAPER Moradi E, Prakash M, Hall A, Solomon A, Strange B, Tohka J, Alzheimer’s Disease Neuroimaging Initiative
Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals.
Alzheimers Res Ther. 2024 Feb 27;16(1):46. PubMed: 38414035PAPER Park JH
Non-equivalence of sub-tasks of the Rey-Osterrieth Complex Figure Test with convolutional neural networks to discriminate mild cognitive impairment.
BMC Psychiatry. 2024 Feb 27;24(1):166. PubMed: 38413893PAPER Shim KH, Kim D, Kang MJ, Pyun JM, Park YH, Youn YC, Park KW, Suk K, Lee HW, Gomes BF, Zetterberg H, An SS, Kim S, Alzheimer's Disease All Markers (ADAM) Research group
Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease.
Alzheimers Dement. 2024 Feb 27; PubMed: 38411315PAPER Marcolini S, Mondragón JD, Dominguez-Vega ZT, De Deyn PP, Maurits NM, Alzheimer's Disease Neuroimaging Initiative
Clinical variables contributing to the identification of biologically defined subgroups within cognitively unimpaired and mild cognitive impairment individuals.
Eur J Neurol. 2024 Feb 27;:e16235. PubMed: 38411289Current Filters
No filters selected